Fennec Pharmaceuticals Inc: chief commercial officer Evans Terry L bought 2,326 shares

What happened

• Terry L Evans, the chief commercial officer, bought 2,326 shares of Fennec Pharmaceuticals Inc common stock at $5.53 per share on Oct 12, 2026, for a total of $12,863. The transaction is reported on a Form 4 as an acquisition (code A).

Key details

• Transaction date and price: Oct 12, 2026 at $5.53 per share.
• Transaction code: A (grant, award or other acquisition).
• Shares owned after the transaction: not reported in the filing.
• Footnote F1: shares were acquired pursuant to the Fennec Pharmaceuticals Inc. Employee Stock Purchase Plan for the ESPP purchase period of Apr 9, 2026 through Oct 12, 2026.
• Footnote F2: in accordance with the ESPP, shares were purchased based on 85% of the closing price of the issuer's common stock on the Nasdaq Capital Market on Apr 9, 2026.
• Filing timeliness: not indicated in the filing.

Why it may matter

• The filing shows a purchase under the issuer's employee stock purchase plan rather than a market sale or a gift.
• This filing does not show why the insider traded or why the company acted.